BRIEF published on 09/13/2024 at 18:05, 2 months 7 days ago Availability of the 2024 half-yearly financial report by Roche Bobois Financial Report International Market 2024 Roche Bobois Furnishings
BRIEF published on 09/11/2024 at 18:05, 2 months 9 days ago Roche Bobois 2024 Half-Year Results: In Line with Expectations EBITDA Financial Situation Half-year Results Turnover Roche Bobois
PRESS RELEASE published on 09/11/2024 at 18:00, 2 months 9 days ago H1 2024 RESULTS IN LINE WITH EXPECTATIONS Roche Bobois SA reports H1 2024 results in line with expectations. Revenue at €204.4m, EBITDA at €36.6m. Solid financial position with available cash of €65.5m EBITDA Revenue Financial Position Roche Bobois SA H1 2024 Results
BRIEF published on 09/09/2024 at 17:55, 2 months 11 days ago Roche Bobois announces the repurchase of its own shares Share Buyback Roche Bobois Stock Market Transactions September 2024 Buyback Programs
BRIEF published on 09/02/2024 at 19:35, 2 months 18 days ago Roche Bobois announces the repurchase of its own shares Financial Information Euronext Share Buyback Roche Bobois Stock Market Transactions
BRIEF published on 09/02/2024 at 19:15, 2 months 18 days ago ROCHE BOBOIS: Monthly Information Relating to Voting Rights Voting Rights Governance Actions Transparency Roche Bobois
BRIEF published on 08/28/2024 at 17:50, 2 months 23 days ago Roche Bobois launches a share buyback program Share Buyback Roche Bobois Authorized Program August 2024 Euronext Transactions
BRIEF published on 08/21/2024 at 17:50, 2 months 30 days ago Roche Bobois: Repurchase of Own Shares in August 2024 Euronext Share Buyback Financial Transactions Roche Bobois August 2024
BRIEF published on 08/16/2024 at 17:50, 3 months 4 days ago Roche Bobois: Monthly Information Relating to Voting Rights Share Capital Voting Rights AMF 2024 Roche Bobois
BRIEF published on 08/13/2024 at 17:50, 3 months 7 days ago Roche Bobois buys back its own shares Euronext Share Buyback Investment Own Shares Roche Bobois
Published on 11/21/2024 at 13:30, 29 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 29 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 59 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 59 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 59 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 24 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 44 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 1 minute ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 39 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 14 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 14 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
